SCARLETRED Presenting at the 6th Dermatology Drug Development Summit in Boston
DE
EN

SCARLETRED Presenting at the 6th Dermatology Drug Development Summit in Boston

Author

The 6th Dermatology Drug Development Summit for inflammatory skin diseases gives insight into novel therapeutics and patient-specific and alternative treatment options currently in clinical trials for various skin diseases.

This year’s summit highlights moderate-to-severe, chronic inflammatory skin conditions and their need for incorporating the patient perspective from clinical trials to drug development for the best-in-class therapies. It focuses on genetic discoveries, antibody drug development, delivery strategies, and predictive and diagnostic technologies for safe and effective drug development.

In addition, the summit added two new tracks: Track A focusing on diseases targeting IL-4, IL-13, & IL-31, and Track B focusing on IL-17, rare diseases, and other autoimmune conditions. SCARLETRED’s CEO, Harald Schnidar, Ph.D., MBA, is invited as an expert speaker and will present our latest clinical validation and study results of our imaging and analysis technology Scarletred®Vision in Rosacea and Hidradenitis Suppurativa.

Register online and check out the complete event Guide on the homepage of the 6th Dermatology Drug Development Summit.

Use the code SPK10 to get 10% off your tickets.

Keywords:Certified, CE class 1m medical device, ISO13485
Download PDF

Like the article? Spread the word

linkedin-icon

Related Applications

Related Events

Events

6th Dermatology Drug Development Summit Boston

November 1, 2022
Boston, MA, USA

CEO Harald Schnidar, PhD, MBA, will attend the summit as an expert speaker.

Find out more